POTTER'S HOUSE APOTHECARY Revenue and Competitors

Peoria, AZ

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • POTTER'S HOUSE APOTHECARY's estimated annual revenue is currently $8.4M per year.(i)
  • POTTER'S HOUSE APOTHECARY's estimated revenue per employee is $201,000

Employee Data

  • POTTER'S HOUSE APOTHECARY has 42 Employees.(i)
  • POTTER'S HOUSE APOTHECARY grew their employee count by 20% last year.

POTTER'S HOUSE APOTHECARY's People

NameTitleEmail/Phone
1
Director Sales and MarketingReveal Email/Phone
2
Laboratory ManagerReveal Email/Phone
3
Lead PharmacistReveal Email/Phone
4
Pharmacist-in-ChargeReveal Email/Phone
5
Patient Care CoordinatorReveal Email/Phone
6
Product and Service SpecialistReveal Email/Phone
7
Specialty Sales RepresentativeReveal Email/Phone
8
Pharmacy TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.3M13118%N/AN/A
#2
$17.7M880%N/AN/A
#3
$8M40-9%N/AN/A
#4
$35.2M17547%N/AN/A
#5
$1.4M7-53%N/AN/A
#6
$2.4M129%N/AN/A
#7
$4.6M23-4%N/AN/A
#8
$37.4M1868%N/AN/A
#9
$53.7M26716%N/AN/A
#10
$2.6M13-19%N/AN/A
Add Company

What Is POTTER'S HOUSE APOTHECARY?

Recognized as a Top Company to Work for in Arizona, Potter's House Apothecary is a PCAB Accredited Pharmacy specializing in both sterile and general compounding that serves the entire state of Arizona. Compounding is the art and science of hand making prescription medications per a doctor's order specifically for a patient and their unique needs. Valley healthcare providers often rely on Potter's House to provide medications with alternative ingredients, strengths, and dosage forms to their patients whose medical conditions often make using a commercially available product impossible.

keywords:N/A

N/A

Total Funding

42

Number of Employees

$8.4M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.1M422%N/A
#2
$7.6M42-11%N/A
#3
$7.1M4220%N/A
#4
$5M4319%N/A
#5
$7.8M43-9%N/A